Radioimmunotherapy Pages on BioPortfolio:

BioPortfolio - Radioimmunotherapy
Radioimmunotherapy - BioPortfolio - Indepth. ... BioPortfolio Ltd. offers e-mail and postal lists for Radioimmunotherapy scientists - we have details of ...
http://www.bioportfolio.com/indepth/Radioimmunotherapy.html...

Biotechnology News FDA fy. cr. dewaal. stronger. allianc. dorman ...
Approval would make Zevalin only Radioimmunotherapy in U.S.. to be Indicated for Use in First-Line Therapy SEATTLE, Oct. 2 /PRNewswire-FirstCall/ -- Cell ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Radioimmunotherapy
BioPortfolio Ltd. offers e-mail and postal lists for Radioimmunotherapy scientists ... perspectives of molecular imaging and radioimmunotherapy in
lymphoma ...
http://www.bioportfolio.com/search/Radioimmunotherapy.html...

BioPortfolio - Radioimmunotherapy - InDepth
View the current Radioimmunotherapy InDepth page on BioPortfolio.com ... [ Clinical indications of radioimmunotherapy in lymphoma] ...
http://www.bioportfolio.com/indepth/Radioimmunotherapy.pdf...

BioPortfolio - perspectives of molecular imaging and ...
perspectives of molecular imaging and radioimmunotherapy in lymphoma - BioPortfolio. ... Several studies reported on the radioimmunotherapy of lymphoma
...
http://www.bioportfolio.com/search/_perspectives_of_molecula...

BioPortfolio - Radioimmunotherapy news
Radioimmunotherapy news - BioPortfolio - Indepth. ... Click here to return to the Radioimmunotherapy main in depth entry. ...
http://www.bioportfolio.com/indepth/Radioimmunotherapy/news....

BioPortfolio - anti-B1 antibody
Targeted monoclonal antibody therapy and radioimmunotherapy for . ... Patient specific radioimmunotherapy of non-Hodgkin's lymphoma . ...
http://www.bioportfolio.com/search/anti-B1_antibody_.html...

BioEmail – Email lists for specifically targeting professionals ...
Radioimmunotherapy of non-Hodgkin's lymphomas. xxx@UMCUtrecht.nl. Biologically effective dose in total-body irradiation and hematopoietic stem cell ...
http://www.bioportfolio.com/pdf/leukemia-listinfo.pdf...

Results from other life science and pharmaceutical sites:

Nature Clinical Practice Oncology | Should radioimmunotherapy be ...
Should radioimmunotherapy be an initial treatment option in advanced-stage ... Radioimmunotherapy is a promising single-agent therapy in advanced stage ...
http://www.nature.com/ncponc/journal/v2/n7/full/ncponc0227.h...

Radioimmunotherapy in relapsed follicular lymphoma...[Leuk ...
Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature
...
http://www.ncbi.nlm.nih.gov/pubmed/18661403...

Radioimmunotherapy for Acute Leukemia
Radioimmunotherapy can improve the long-term outcome for patients with leukemia.
http://www.medscape.com/viewarticle/433841_3...

Radioimmunotherapy and apoptotic induction on CK19...[Anticancer ...
The strategy and mechanism of radioimmunotherapy using Re-188-mAbCx-99 to Ck19 on human cervical carcinoma cells was investigated in this study. ...
http://www.ncbi.nlm.nih.gov/pubmed/16080517...

Radiobiology of radioimmunotherapy with 90Y ibritu...[Semin Oncol ...
Radioimmunotherapy represents a significant advance over unlabeled immunotherapy for the treatment of patients with B-cell non-Hodgkin's lymphoma. ...
http://www.ncbi.nlm.nih.gov/pubmed/14710397...

PET Plays a Role in Radioimmunotherapy for NHL
18 Jun 2008 ... FDG-PET has been shown to be a valuable tool for selecting candidates for treatment with yttrium 90 ibritumomab tiuxetan in some patients ...
http://www.medscape.com/viewarticle/576254...

Radioimmunotherapy with iodine (131)I tositumomab ...[Blood. 2000 ...
CD20-targeted radioimmunotherapy is a promising new treatment for B-cell non- Hodgkin ... 2005]; Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.
...
http://www.ncbi.nlm.nih.gov/pubmed/10942366...

Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in ...
Three-step radioimmunotherapy promises to have an important role as adjuvant ... Intralesional radioimmunotherapy (RIT) for high grade gliomas using ...
http://www.nature.com/bjc/journal/v86/n2/full/6600047a.html...

Ibritumomab tiuxetan radioimmunotherapy for patien...[Blood. 2002 ...
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter ...
http://www.ncbi.nlm.nih.gov/pubmed/12036859...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.